There are no particular restrictions.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who have been diagnosed with oral ranula at the study facility and are scheduled for marsupialization. 2. No age or gender restrictions. 3. Not matter whether the patient is an inpatient or an outpatient. 4. Patients who have given consent to participate in this clinical study from themselves or their family members. If the patient is a minor, consent has been obtained from a legal representative (parent, guardian, or equivalent). However, if the patient is 16 years of age or older, consent has been obtained from the patient themselves in addition to written consent from a legal representative.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of hypersensitivity to steroid ointments (dexamethasone ointment). 2. Patients with pituitary/adrenal disease. 3. Patients with oral infections. 4. Patients who are scheduled to receive steroid treatment such as oral administration, infusion, or inhalation during the clinical study. 5. Pregnant patients. Patients who are breastfeeding and find it difficult to discontinue breastfeeding during this treatment. 6. Patients who have difficulty applying steroid ointment (dexamethasone ointment) by themselves or their families. 7. Patients who are deemed unsuitable as clinical study subjects by the principal investigator/subinvestigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether or not mucous retention cysts of the floor of the mouth recur. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Recurrence-free rate 2. Surgery time 3. Postoperative complications within 1 month of starting treatment | — |
Contacts
Nagoya City University Hospital